Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary TBE Vaccination for the Elderly
2019-002541-37Phase 4Active
- Sponsor
- Region Örebro län
- Start
- Sep 2019
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE) (2 arms), sponsored by Region Örebro län. Primary endpoint: Neutralizing antibodies after primary series and booster. Started Sep 2019; status: active.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2019-002541-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002541-37.